Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.5.5 (
CPS
)
1,262
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
As a result of recent advances in molecular cloning, protein expression, and X-ray crystallography, it has now become feasible to examine complicated protein structures at high resolution. For those enzymes with multiple catalytic sites, a common theme is beginning to emerge; the existence of molecular tunnels that connect one active site with another. The apparent mechanistic advantages rendered by these molecular conduits include the protection of unstable intermediates and an improvement in catalytic efficiency by blocking the diffusion of intermediates into the bulk solvent. Since the first molecular tunnel within tryptophan synthase was discovered in 1988, tunnels within
carbamoyl phosphate synthetase
, glutamine phosphoribosylpyrophosphate amidotransferase, asparagine synthetase, glutamate synthase, imidazole glycerol phosphate synthase,
glucosamine 6-phosphate synthase
, and carbon monoxide dehydrogenase/acetyl-CoA synthase have been identified. The translocation of ammonia, derived from the hydrolysis of glutamine, is the most abundant functional requirement for a protein tunnel identified thus far. Here we describe and summarize our current understanding of molecular tunnels observed in various enzyme systems.
...
PMID:Enzymes with molecular tunnels. 1285 15